Welcome to the Merck & Company Q4 sales and earnings conference call. [Operator instructions] This call is being recorded.
Reports Q4 revenue $15.6B, consensus $15.51B. “We delivered strong growth in 2024, reflecting demand for our innovative portfolio, including ...
Merck MRK will report its fourth-quarter and full-year 2024 earnings on Feb. 4, before market open. The Zacks Consensus Estimate for sales and earnings is pegged at $15.56 billion and $1.72 per ...
Shares of Merck (NYSE: MRK) were trading lower on Tuesday. The drop comes as the S&P 500 gained 0.5% and the Nasdaq Composite ...
MRK provided 2025 adjusted EPS guidance of $8.88 to $9.03, while the giant drugmaker expects sales of $64.1 billion to $65.6 ...
With a market cap of $252.6 billion, Rahway, New Jersey-based Merck & Co., Inc. (MRK ... It is expected to unveil its fiscal Q4 earnings results before the market opens on Tuesday, Feb. 4.
Good morning, and welcome to Aramark's First Quarter Fiscal 2025 Earnings Results Conference Call. My name is Tanya, and I will be your operator for today's call. At this time, I would like to inform ...
Merck’s stock tumbled 6% early Tuesday, after the drug company’s softer-than-expected guidance for the current year offset better-than-expected fourth-quarter earnings. Rahway, N.J.-based Merck had ...